Last reviewed · How we verify
NCT06942130
The Application of Artificial Intelligence in Dental Education
NA trial testing Artificial intelligence in Medical Education in 192 participants. Completed in 2 November 2024.
2 November 2024
Quick facts
| Lead sponsor | Hospital of Stomatology, Wuhan University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | other |
| Enrollment | 192 |
| Start date | 1 October 2024 |
| Primary completion | 2 November 2024 |
| Estimated completion | 2 November 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- Artificial intelligence
- Video
Conditions studied
- Medical Education — all drugs for Medical Education →
Sponsor
Hospital of Stomatology, Wuhan University
Who can join
Eligibility, any sex, with Medical Education. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Clinical procedural skills training is a cornerstone of preclinical education for dental students. While technological aids such as virtual reality and simulators are increasingly integrated into training, direct instructor guidance remains fundamental to skill development. Artificial intelligence（AI）， as an emerging technology, is now gradually being adopted in medical education. This medical education trial, aimed at evaluating the potential of artificial intelligence in dental education, seeks to address two key questions: 1) Can AI assistance enhance the skill performance of dental students? 2) How can AI be effectively integrated into modern medical education? Researchers will compare the effects of AI and video-based instruction on skill acquisition, assessing differences in skill performance outcomes. Participants will engage in skill acquisition using either AI or video-based instruction over a one-week period.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Exploring the Application Capability of ChatGPT as an Instructor in Skills Education for Dental Medical Students: Randomized Controlled Trial.
Huang S, Wen C, Bai X, Li S, et al · · 2025 · cited 4× · PMID 40424023 · DOI 10.2196/68538
Verify or expand the search:
- PubMed search for NCT06942130
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Artificial intelligence
Trials testing the same drug.
- NCT06268418 — Pre-therapeutic 68Ga-PSMA PET AI Based Dose Prediction for 177Lu-PSMA Targeted Radionuclide Therapy · completed
- NCT06667635 — Intelligent Analysis and Clinical Validation of Cerebral Small Vessel Disease on Magnetic Resonance Imaging：A Multi-cent · not yet recruiting
- NCT05985057 — A Novel Approach to Antimicrobial Resistance: Machine Learning Predictions for Carbapenem-Resistant Klebsiella in ICUs · completed
- NCT06051682 — Optimization of the Diagnosis of Bone Fractures in Patients Treated in the Emergency Department by Using Artificial Inte · NA · unknown
- NCT05863208 — Artificial Intelligence-assisted Colonoscopy With or Without Endocuff Vision · NA · recruiting
Other recruiting trials for Medical Education
Currently open trials in the same condition.
- NCT07367906 — Digital Microlearning and Patient Safety in Nursing Students · NA · recruiting
- NCT07305077 — One-Minute Preceptor to Improve Bedside Teaching · NA · recruiting
- NCT07006337 — Surgical Operating Room Enhancement Curriculum for Medical Students · NA · recruiting
- NCT07449182 — An AI Educational Agent for Medical Machine Learning Courses · NA · recruiting
- NCT06753266 — Optimizing OR Simulation in MEDI 045: Bias Reduction and Strategic Improvements (OPTIMIST) · active not recruiting
Other Hospital of Stomatology, Wuhan University trials
Trials by the same sponsor.
- NCT05798793 — Neoadjuvant Anti-PD-1 Immunotherapy With Chemotherapy in Resectable Locally Advanced Oral Squamous Cell Carcinoma · Phase 3 · recruiting
- NCT06277791 — The Combination of Adebrelimab and TP Regimen for Neoadjuvant Therapy in Patients With Stage IVB Oral Squamous Cell Carc · Phase 2 · recruiting
- NCT04649476 — Neoadjuvant PD-1 Blockade in Resectable Oral Squamous Cell Carcinoma · Phase 2 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06942130 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital of Stomatology, Wuhan University
- Last refreshed: 24 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06942130.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing